Drug Trial Radar · NCT00439413
Selegiline for Smoking Cessation - 1
Last checked: Nov 20, 2026Latest source record: Feb 2, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
246
Actual
Start
Jun 2007
Primary completion
Aug 2008
Study completion Jan 2009
Sponsor
- Lead sponsor
- National Institute on Drug Abuse (NIDA)NIH
- Sponsor type
- NIH
- Collaborators
- VA Office of Research and Development
- First posted
- Feb 23, 2007
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 99 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is designed to examine the effects of Selegiline Transdermal System and behavioral intervention in smoking cessation as compared to behavioral intervention alone.
Conditions
- Nicotine Dependence
Interventions
Selegiline Transdermal PatchDrug
Selegiline cm(2) via transdermal system
PlaceboDrug
Matching placebo via transdermal system
Smoking Cessation CounselingBehavioral
Subjects were provided with on-site, individual smoking cessation counseling sessions 1x per week for 9 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Quit RateTime frame: Study weeks 6 through 9
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Department of Public & Community Health
College Park, Maryland
Robert Wood Johnson Med School-Tobacco Dep Program
New Brunswick, New Jersey
Tri-State Tobacco and Alcohol Research Center
Cincinnati, Ohio
Center For Tobacco Research and Intervention
Milwaukee, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.